105 related articles for article (PubMed ID: 8400190)
1. [The effect of low doses of dexamethasone on interleukin-2 production by human peripheral blood lymphocytes].
Kalashnikova EA; Pukhal'skiĭ AL
Biull Eksp Biol Med; 1993 Jul; 116(7):68-70. PubMed ID: 8400190
[TBL] [Abstract][Full Text] [Related]
2. Lymphokine (interleukin-2) production by mitogen-stimulated human lymphocytes in small reactors.
Bödeker BG; Lehmann J; Mühlradt PF
Dev Biol Stand; 1981; 50():193-200. PubMed ID: 6978826
[TBL] [Abstract][Full Text] [Related]
3. Effects of dexamethasone on lymphocyte proliferation and cytokine production in rheumatoid arthritis.
De A; Blotta HM; Mamoni RL; Louzada P; Bertolo MB; Foss NT; Moreira AC; Castro M
J Rheumatol; 2002 Jan; 29(1):46-51. PubMed ID: 11824970
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors regulate interleukin-2 synthesis of stimulated lymphocytes: consequence for production procedures.
Bödeker BG; Mühlradt PF
Dev Biol Stand; 1983; 55():247-54. PubMed ID: 6610588
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulating effects of tofizopam (Grandaxin) and diazepam in vitro.
Kalashnikov SV; Kalashnikova EA; Kokarovtseva SN
Mediators Inflamm; 2002 Feb; 11(1):53-9. PubMed ID: 11926595
[TBL] [Abstract][Full Text] [Related]
6. Early calcium signaling and calcium requirements for the IL-2 receptor expression and IL-2 production in stimulated lymphocytes.
Komada H; Nakabayashi H; Hara M; Izutsu K
Cell Immunol; 1996 Nov; 173(2):215-20. PubMed ID: 8912879
[TBL] [Abstract][Full Text] [Related]
7. Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.
Rayman P; Uzzo RG; Kolenko V; Bloom T; Cathcart MK; Molto L; Novick AC; Bukowski RM; Hamilton T; Finke JH
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S81-7. PubMed ID: 10685665
[TBL] [Abstract][Full Text] [Related]
8. IL-2-induced IL-9 production by allergen-specific human helper T-cell clones.
Kajiyama Y; Umezu-Goto M; Kobayashi N; Takahashi K; Fukuchi Y; Mori A
Int Arch Allergy Immunol; 2007; 143 Suppl 1():71-5. PubMed ID: 17541281
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 2 synthesis in the presence of steroids: a model of steroid resistance.
Walker KB; Potter JM; House AK
Clin Exp Immunol; 1987 Apr; 68(1):162-7. PubMed ID: 3498565
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide-releasing compounds inhibit the production of interleukin-2, -4 and -10 in activated human lymphocytes.
Korhonen R; Kosonen O; Hämäläinen M; Moilanen E
Basic Clin Pharmacol Toxicol; 2008 Oct; 103(4):322-8. PubMed ID: 18684225
[TBL] [Abstract][Full Text] [Related]
11. Cocaine down-regulates IL-2-induced peripheral blood lymphocyte IL-8 and IFN-gamma production.
Mao JT; Huang M; Wang J; Sharma S; Tashkin DP; Dubinett SM
Cell Immunol; 1996 Sep; 172(2):217-23. PubMed ID: 8964083
[TBL] [Abstract][Full Text] [Related]
12. Influence of ascorbic acid on the response to mitogens and interleukin production of porcine lymphocytes.
Schwager J; Schulze J
Int J Vitam Nutr Res; 1997; 67(1):10-6. PubMed ID: 9119607
[TBL] [Abstract][Full Text] [Related]
13. Activated alpha 2-macroglobulin reverses the immunosuppressive activity in human breast cancer cell-conditioned medium by selectively neutralizing transforming growth factor-beta in the presence of interleukin-2.
Harthun NL; Weaver AM; Brinckerhoff LH; Deacon DH; Gonias SL; Slingluff CL
J Immunother; 1998 Mar; 21(2):85-94. PubMed ID: 9551359
[TBL] [Abstract][Full Text] [Related]
14. [Production of interleukin-2 by peripheral blood lymphocytes from patients with soft tissue sarcomas].
Berezhnaia NM; Goretskiĭ BA; Konovalenko VF; Palivets AIu; Tolstopiatov BA
Eksp Onkol; 1987; 9(4):60-2. PubMed ID: 3500035
[TBL] [Abstract][Full Text] [Related]
15. In vitro production of interleukin-2 by lymphocytes in whole blood and isolated culture.
Lyte M
J Clin Lab Immunol; 1988 Aug; 26(4):189-93. PubMed ID: 3264345
[TBL] [Abstract][Full Text] [Related]
16. Potent and selective inhibition of in vitro lymphocyte migration by cyclosporine and dexamethasone.
Ross JS; Bacon KB; Camp RD
Immunopharmacol Immunotoxicol; 1990; 12(3):439-55. PubMed ID: 2176229
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoids inhibit CD40 ligand expression of peripheral CD4+ lymphocytes.
Bischof F; Melms A
Cell Immunol; 1998 Jul; 187(1):38-44. PubMed ID: 9682002
[TBL] [Abstract][Full Text] [Related]
18. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications.
Elenkov IJ; Papanicolaou DA; Wilder RL; Chrousos GP
Proc Assoc Am Physicians; 1996 Sep; 108(5):374-81. PubMed ID: 8902882
[TBL] [Abstract][Full Text] [Related]
19. Modulation of T lymphocyte function by neuropeptides. Evidence for their role as local immunoregulatory elements.
Nio DA; Moylan RN; Roche JK
J Immunol; 1993 Jun; 150(12):5281-8. PubMed ID: 8515059
[TBL] [Abstract][Full Text] [Related]
20. Differences in iron requirements by concanavalin A-treated and anti-CD3-treated murine splenic lymphocytes.
Kuvibidila SR; Velez M; Yu L; Warrier RP; Surendra Baliga B
Br J Nutr; 2002 Jul; 88(1):67-72. PubMed ID: 12117429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
